Healthcare provider profile · identity verified

Kelby Jon Wilson, MD

Family Practice · GRANGEVILLE, ID · NPI 1164872115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	350	98
Lisinopril	Lisinopril	297	73
Omeprazole	Omeprazole	286	72
Levothyroxine Sodium	Levothyroxine Sodium	225	55
Losartan Potassium	Losartan Potassium	192	50
Amlodipine Besylate	Amlodipine Besylate	184	49
Tamsulosin Hcl	Tamsulosin Hcl	183	43
Furosemide	Furosemide	178	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	34
Metoprolol Succinate	Metoprolol Succinate	156	36
Metformin Hcl Er	Metformin Hcl	142	40
Gabapentin	Gabapentin	132	36
Potassium Chloride	Potassium Chloride	130	32
Zolpidem Tartrate	Zolpidem Tartrate	92	suppressed
Simvastatin	Simvastatin	89	23
Sertraline Hcl	Sertraline Hcl	86	20
Metformin Hcl	Metformin Hcl	84	19
Pantoprazole Sodium	Pantoprazole Sodium	84	20
Ozempic	Semaglutide	73	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	72	22
Rosuvastatin Calcium	Rosuvastatin Calcium	72	18
Xarelto	Rivaroxaban	69	suppressed
Eliquis	Apixaban	65	14
Finasteride	Finasteride	61	13
Carvedilol	Carvedilol	54	15
Montelukast Sodium	Montelukast Sodium	54	13
Allopurinol	Allopurinol	52	11
Duloxetine Hcl	Duloxetine Hcl	51	14
Tizanidine Hcl	Tizanidine Hcl	51	11
Fluticasone Propionate	Fluticasone Propionate	50	16
Metoprolol Tartrate	Metoprolol Tartrate	49	11
Spironolactone	Spironolactone	49	14
Trazodone Hcl	Trazodone Hcl	47	12
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	13
Prednisone	Prednisone	32	14
Pregabalin	Pregabalin	32	suppressed
Ibuprofen	Ibuprofen	31	11
Jardiance	Empagliflozin	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Naproxen	Naproxen	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Atenolol	Atenolol	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Colchicine	Colchicine	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Carbamazepine Er	Carbamazepine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Famotidine	Famotidine	19	suppressed
Baclofen	Baclofen	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Temazepam	Temazepam	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Aimovig Autoinjector	Erenumab-Aooe	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Glipizide	Glipizide	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nystatin	Nystatin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error